Nanoparticle technology demonstrates selective destruction of leukemia cancer cells

Nanoparticle technology demonstrates selective destruction of leukemia cancer cells- A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), offering the potential to reduce side effects while enhancing therapeutic efficacy by selectively targeting and eliminating leukemia cells.

Source: phys.org

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *